0001140361-23-010159.txt : 20230303 0001140361-23-010159.hdr.sgml : 20230303 20230303204957 ACCESSION NUMBER: 0001140361-23-010159 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230301 FILED AS OF DATE: 20230303 DATE AS OF CHANGE: 20230303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelly-Croswell Lisa CENTRAL INDEX KEY: 0001845596 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36183 FILM NUMBER: 23707276 MAIL ADDRESS: STREET 1: C/O SYNLOGIC, INC. STREET 2: 301 BINNEY STREET, SUITE 402 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc. CENTRAL INDEX KEY: 0001305253 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 361004130 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-279-9845 MAIL ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: Celladon Corp DATE OF NAME CHANGE: 20041005 4 1 form4.xml X0306 4 2023-03-01 0001305253 Eiger BioPharmaceuticals, Inc. EIGR 0001845596 Kelly-Croswell Lisa C/O EIGER BIOPHARMACEUTICALS, INC. 2155 PARK BLVD. PALO ALTO CA 94306 true Stock Option (Right to Buy) 1.705 2023-03-01 4 A 0 28000 0 A 2033-02-28 Common Stock 28000 28000 D The option vests in equal monthly installments over 12 months measured from March 1, 2023, subject to Reporting Person's continuous service status as of each such date. /s/ Lisa Kelly-Croswell 2023-03-03